RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma

Published:2023 Issue:4 Volume:34 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Kim Kyeongmin¹²^ORCID,Kim Se Hoon¹^ORCID,Lee Jung-Yun³^ORCID,Kim Yoo-Na³^ORCID,Lee Seung-Tae⁴^ORCID,Park Eunhyang¹^ORCID

Affiliation:

1. Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Pathology, Soonchunhyang University, Seoul, Korea.

3. Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.

4. Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Yonsei University College of Medicine

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2023.34.e45

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

3. Cancer statistics, 2020

4. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

5. A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer;Frontiers in Oncology;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3